Bovine supplements for newborn calves

A highly viscous, natural caffeine-based supplement for newborn calves addresses hypoxia and abnormal calving by enhancing mucosal absorption and colostrum intake, ensuring vitality and nutrition through rapid caffeine delivery.

JP2024541750AInactive Publication Date: 2024-11-12TECHMIX LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023578180
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-06-18
Filing Date
2022-08-11
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing nutritional supplements for newborn calves, such as those containing synthetic caffeine or low viscosity liquids, are ineffective in treating hypoxia and abnormal calving due to low caffeine content and inability to adhere to the oral mucosa, leading to impaired colostrum absorption and increased risk of death.

Method used

A highly viscous, stable liquid bovine supplement containing natural caffeine from green tea extract, xanthan gum, and corn syrup, designed for mucosal absorption, with optional antioxidants and electrolytes to stimulate respiration and nutrition uptake.

Benefits of technology

The supplement effectively delivers concentrated caffeine for rapid absorption, reducing edema and stimulating respiration, ensuring colostrum intake and overall vitality, thereby reducing the risk of hypoxic complications in newborn calves.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541750000001
    Figure 2024541750000001
  • Figure 2024541750000002
    Figure 2024541750000002
  • Figure 2024541750000003
    Figure 2024541750000003
Patent Text Reader

Abstract

The present invention relates generally to feed supplement preparations for administration to ruminants, and more specifically to a formulation for an oral bovine supplement for newborn calves that delivers natural caffeine, and optionally antioxidants and other electrolytes, in a stable liquid form of high viscosity. A 10-40 ml liquid dose containing green tea extract delivers a concentrated amount of caffeine to a newborn calf of approximately 100-400 mg.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation-in-part of U.S. Patent Application No. 16 / 117,227, filed August 30, 2018, and is hereby incorporated by reference in its entirety.

[0002] FIELD OF THEINVENTION The present invention relates generally to feed supplement preparations for administration to ruminants, and more specifically to a formulation for an oral bovine supplement for newborn calves that delivers natural caffeine and a viscosity modifier in a stable liquid form for absorption via the oral mucosa of the newborn calf. [Background technology]

[0003] "Bovine dystocia" refers to a condition during the birthing process that makes it difficult or impossible for a cow to deliver the calf without human assistance. It can occur during the first or second stage of birth and typically involves the calf being positioned incorrectly in the birth canal, upside down or even sideways, or otherwise not suited to the shape and size of the birth canal. The incidence of dystocia in dairy cows is reported to range from 2-22%, while the percentage of cows requiring human assistance during birth ranges from 10-50%.

[0004] Contributing factors for bovine dystocia include the birth weight of the calf and the size of the pelvic region of the mother cow ("heifer" or "dam"). Thus, dairy and beef cattle operations often cull heifers with small pelvic regions from their breeding programs and purposely use bulls that have been proven to produce cattle with small birth weights. Providing proper nutrition to heifers prior to the calving process also ensures the calf's ability to exert greater propulsive force through the birth canal. However, even with proper herd management and nutrition policies, many cases of bovine dystocia still occur. Considering the expense and time spent in inseminating and gestating heifers and cows, and the potential injury or death of the mother cow or calf due to dystocia, this can pose a substantial economic risk for dairy or cattle operations.

[0005] In fact, calves that require human assistance during the birthing process experience a 50% higher risk of death. During the birthing process, the fetus experiences neonatal asphyxia, resulting in areas of low blood oxygen levels and reduced blood flow, referred to as "hypoxia." Such hypoxia can progress to anoxia (the absence of oxygen in the blood). Prolonged oxygen deprivation can result in fetal death within six minutes.

[0006] Newborn calves require immediate colostrum supplementation immediately after birth. However, hypoxic newborn calves often suffer from a state of drowsiness and recumbency that impedes their physical ability to stand and drink colostrum. Furthermore, the ability of the newborn calf to absorb immunoglobulins and other components of colostrum is impaired when the newborn calf is hypoxic. Unchecked hypoxia can linger for hours and may overlap with naturally occurring intestinal closure, thereby creating a secondary scenario that worsens or completely halts the passive transfer of immunoglobulins from colostrum. This factor further constitutes the need to support the rapid oxygenation and vitality of the newborn cow. Additionally, a comatose calf will typically also receive supplemental amounts of glucose in an attempt to stimulate muscle contractions and overall vitality. However, such glucose supplementation results in an appetite-reducing insulin response in the newborn calf, resulting in periods of hypoglycemia that further amplify the comatose state. This vicious cycle can be extremely detrimental to the newborn calf during the first 12-24 hours of its life when appetite is critical for colostrum intake.

[0007] Caffeine has been demonstrated as an effective intervention to reduce apnea episodes in human infants. However, caffeine is not considered to be a necessary nutrient for livestock, and therefore synthetic caffeine lacks "Generally Recognized as Safe" ("GRAS") status by the Association of American Feed Control Officials ("AAFCO"). Thus, administering human supplements containing synthetic caffeine to treat hypoxia in calves would be illegal. However, tea has been granted GRAS status by AAFCO, and tea leaves contain the natural form of caffeine.

[0008] Nutritional supplement products containing caffeine are known in the art for humans to improve health.For example, US Patent Application Publication No. 2011 / 0123651 filed by Mower et al. discloses a nutritional beverage used to fight the aging process in humans.It contains resveratrol, which can be sourced from grape skin or in the form of wine produced from grapes and grape skin.Water, a suspending agent such as sodium citrate, and optionally quercetin, an antioxidant and anti-inflammatory agent, are also included in the beverage.Mower further discloses that the beverage also contains catechin, a polyphenol that is highly derived from green tea leaf extract, which promotes genetic stimulation for increased proliferation of beneficial cells in humans.

[0009] However, Mower's anti-aging supplement product contains only trace amounts (i.e., 0.067% wt) of caffeine as a secondary ingredient. He also provides his product in a liquid form that is "buccally delivered" to human customers, who must hold the beverage in their mouth for one minute before swallowing. Needless to say, a newborn calf cannot be expected to delay swallowing a liquid supplement product for a minute while holding it in its mouth to effect delivery of an ingredient such as resveratrol or caffeine via the mouth. Because Mower's product is delivered in liquid form without mucosal adsorption, for this purpose it contains only a very small amount of xanthan gum as a thickening agent.

[0010] U.S. Patent Application Publication No. 2008 / 0038409, filed by Nair et al., discloses a "cocoa water beverage" made from water steeped in coca products or powder. The resulting product is consumed by humans to stimulate the immune system, improve heart health, detoxify, restore muscle, enhance cognitive performance, etc. However, Nair's corn syrup is used as a sweetener, not a viscosity modifier. Similarly, his vegetable oil ingredients are used to prevent oxidation of polyphenol and flavanol compounds extracted from the coca products. He does not use the plant ingredients to facilitate the suspension of green tea extract in a nutritional supplement for newborn calves.

[0011] Caffeine-containing foods, including caffeine provided by green tea extract, are known in the art. For example, U.S. Patent No. 5,879,733 issued to Ekanayake et al. illustrates a green tea extract beverage in which the green tea extract is acid extracted, passed through a cation exchange resin to remove metal cations that cause turbidity, and then passed through nanofiltration to remove high molecular weight components that impair the color and clarity of the beverage. However, Ekanayake's product is not only in a liquid form that is unsuitable for absorption through the oral mucosal lining of newborn calves, but its 0.5% wt green tea concentrate found in sugar-sweetened beverages is significantly lower than the level required to stimulate newborn calves suffering from dystocia or hypoxia. In fact, Ekanayake's references disclose a caffeine level of 992 ppm in his final product. 1000 ppm is equivalent to 0.1% wt, so 992 ppm of caffeine translates to 0.0992% wt of caffeine, which is very low.

[0012] Meanwhile, U.S. Patent No. 5,624,698 issued to Dake et al. teaches a syrup product for use in a "soda fountain" for dispensing dilute juice beverages. The syrup contains flavor components such as green or black tea along with juice flavors. An oil component such as vegetable oil provides the desired opacity and cloudiness to the resulting juice beverage. Xanthan gum is added to the syrup as an emulsifier to prevent dispersion of the oil component which would cause separation from the syrup.

[0013] Even if Dake's syrup product were fed to newborn calves, it would not treat the effects of dystocia. The viscosity of the product, less than 250 cps, preferably less than 150 cps, is simply too low for mucosal delivery of the product to newborn calves. In contrast, Dake intends to add his syrup product to a fountain beverage consumed by humans. Furthermore, Dake only uses his black or green tea ingredients (less than 0.5% wt) as a flavoring, not as a caffeine stimulant. Furthermore, Dake does not mention a target caffeine content for the tea in his final solution.

[0014] Even popular "energy drinks" consumed by humans to provide a quick stimulation are not suitable for treating newborn calves suffering from dystocia. For example, U.S. Patent Application Publication No. 2017 / 0231996 filed by Levi et al. discloses energy drinks containing supersaturated caffeine levels. They contain caffeine at levels of 1.7-3.0% (w / v). They are also disclosed as containing 150-250 mg of caffeine in 9 ml of water. However, this 150 mg in 9 ml of water only delivers 1.66% wt of caffeine. This is a surprisingly low caffeine level. Furthermore, Levi appears to be using synthetic caffeine in the form of caffeine citrate, rather than the natural caffeine sources required by AAFCO regulations for food animals.

[0015] Clif Bar & Co.'s popular "Clif Shot Turbo Double Espresso Energy Gel" product and even more popular "5-Hour Energy" drink only contain caffeine levels of 0.24% wt and 0.43% wt, respectively. Furthermore, the 5-Hour Energy product has a viscosity level of 150 cps or less, which is significantly lower than the viscosity level required for mucosal delivery to newborn calves. Thus, despite what the term "energy gel" may suggest, these types of products are not viscous enough to reliably retain in the mouth of a newborn calf and deliver caffeine across the mucosal lining.

[0016] Thus, it would be highly beneficial to provide a bovine supplement for newborn calves that contains non-synthetic caffeine as a stimulant to encourage the calf to consume colostrum, stimulate its respiration, and reduce edema to enable it to survive the effects of bovine dystocia and hypoxia. Such a bovine supplement should exhibit a relatively high viscosity level for mucosal delivery of the supplement's ingredients to the calf. Summary of the Invention

[0017] Provided by the present invention is a neonatal bovine nutritional supplement that is fed to newborn calves to enhance nutritional intake during this vulnerable early stage of the calf's life. Bovine dystocia can weaken the newborn calf and cause generalized restraint and recumbency that prevents the newborn calf from standing up to consume colostrum. The neonatal bovine nutritional supplement includes non-synthetic caffeine obtained from natural sources such as green tea extract, and viscosity modifiers such as corn syrup and xanthan gum or guar gum that increase the viscosity of the liquid supplement to about 400-800 centipoise at 21° C., so that the supplement is absorbed by the newborn calf through its oral mucosal lining in the newborn calf's mouth and tongue. The specific gravity (relative density) of the supplement product is preferably in the range of about 0.9-1.6. The neonatal bovine nutritional supplement may optionally include antioxidants and electrolytes.

[0018] Thus, the supplement reliably supplies the newborn calf with caffeine to reduce edema that may otherwise interfere with the newborn calf's vital nutritional intake of colostrum and other animal feed ingredients within hours of birth, stimulate respiration, and increase the newborn calf's energy levels. Furthermore, the concentrated caffeine level in the green tea extract allows a 10-40 ml dose of liquid solution supplement product to contain approximately 100-400 mg of caffeine for delivery to the newborn calf without stomach fullness that may otherwise prompt the newborn calf to stop consuming colostrum and other important animal feed ingredients. Furthermore, this novel formulation of bovine supplement for newborn calves delivers natural caffeine in a highly viscous stable liquid form that may optionally contain antioxidants and other electrolytes. The supplement successfully incorporates natural caffeine as a highly concentrated liquid oral dose formulation where the viscosity of the liquid supplement is such that it facilitates adhesion to the tongue and oral cavity, thereby facilitating mucosal absorption and greatly enhancing the effectiveness of the supplement. Additionally, the concentrated nature of the product allows for the delivery of a minimal amount of caffeine, thereby minimizing satiety and therefore ensuring adequate intake of sufficient amounts of colostrum.

[0019] The formulation has been successfully supplemented with natural caffeine in the form of green tea, which may be an extract, which is also rich in antioxidants, and the formulation contains a high concentration of caffeine in a proprietary mixture of xanthan or guar gum, corn syrup, water and electrolytes. The corn syrup and xanthan gum are added to adjust the viscosity so that the solution adheres to the mouth and tongue, allowing for more rapid absorption of the caffeine. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] To overcome the adverse effects of dystocia, a unique formulation for a newborn calf supplement administered after birth is provided by the present invention that delivers a natural, concentrated dose of caffeine, antioxidants, and electrolytes, for example, provided by green tea extract. The supplement successfully incorporates viscosity modifiers such as xanthan gum or guar gum and corn syrup to produce a product that remains shelf stable in liquid form while greatly enhancing the effectiveness of the supplement for absorption through the newborn calf's oral mucosa for rapid treatment. The supplement not only provides the necessary multisystem (i.e., CNS / cardiac / respiratory) stimulation for the newly born calf, but also stimulates respiration, reduces edema, and stimulates muscle contraction. Thus, the supplement treats the three biggest problems faced by hypoxic calves: lethargy, respiratory rate, and high levels of adenosine.

[0021] The neonatal calf nutritional supplement of the present invention comprises a concentrated dose of non-synthetic caffeine and water in a liquid solution modified by a viscosity modifier to provide a viscosity of about 400-800 centipoise ("cps"), preferably about 500-650 cps, and even more preferably about 600 cps at 21°C, such that when the supplement is introduced into the mouth of a neonatal calf suffering from dystocia or hypoxia, the supplement adheres to the tongue and inside of the cheeks in the mouth of the neonatal calf for rapid absorption of caffeine through the mucosal lining. Due to the proximity of blood vessels to the oral mucosal surface of the neonatal calf, this allows for much faster entry of caffeine into the circulatory system compared to the digestive system, where ingested products may take several hours to enter the circulatory system. The neonatal calf nutritional supplement may contain several other optional ingredients to produce a stable solution that enhances the health of neonatal calves under constraint, including antioxidants, electrolytes, solubilizers, antifoaming agents, and preservatives.

[0022] For neonatal calf nutritional supplements, non-synthetic caffeine may be provided from a variety of natural caffeine sources that are not chemically synthesized. Such non-synthetic caffeine sources include green tea, green tea extract, black tea, coffee, and cocoa. Green tea extract having a caffeine level of about 90%, preferably about 99%, is preferred. The non-synthetic caffeine component should comprise about 1-15% wt, preferably about 1-5% wt, of the formulated neonatal calf nutritional supplement product.

[0023] The water component of the newborn calf nutritional supplement product may be tap water or deionized water. The water should be clean and free of any contaminants that would be harmful to the health of the newborn calf. The water component should comprise about 30-60% wt, preferably 35-50% wt, and even more preferably about 39% wt of the formulated newborn calf nutritional supplement product.

[0024] One or more thickening agents should be added to the solution containing water, non-synthetic caffeine, and trisodium citrate to obtain a desired viscosity level of about 400-800 cps, preferably about 500-650 cps, and even more preferably about 600 cps at 21° C. Corn syrup can be used to enhance the viscosity of the resulting newborn calf nutritional supplement product, although other suitable alternative viscosity enhancing ingredients include molasses, glycerin, vegetable oil, glucose syrup, and high fructose syrup. The corn syrup or alternative viscosity enhancing agent should comprise about 40-75% wt, preferably about 50-60% wt, of the formulated newborn calf nutritional supplement product.

[0025] A second viscosity adjusting component to further thicken the neonatal calf nutritional supplement product may be xanthan gum, but may also be guar gum, corn starch, potato starch, or an acid such as citric acid, formic acid, ascorbic acid, acetic acid, or phosphoric acid. This additional thickening agent should only comprise about 0.05-5.0% wt, preferably about 0.05-0.20% wt, of the formulated neonatal calf nutritional supplement product.

[0026] The neonatal calf nutritional supplement of the present invention may also contain one or more antioxidants. Such antioxidants will address the increase in free radicals in neonatal calves caused by the lack of oxygen during the birth process. Caffeine functions as an antioxidant for the supplement product of the present invention. As mentioned above, suitable non-synthetic sources of caffeine include green tea, green tea extract, black tea, coffee, and cocoa. Therefore, it is advantageous to have the caffeine source perform two functions in the product formulation by further providing antioxidant function. Green tea extract is preferred for providing antioxidant to neonatal calves.

[0027] Sodium citrate can be added to the product formulation to solubilize the caffeine component in solution and make the antioxidants more accessible to the newborn calf. Sodium citrate will also reduce metabolic acidosis in the newborn calf caused by hypoxia, or fluid imbalance. It buffers the newborn calf's blood to the proper pH level.

[0028] The sodium resulting from dissociation from sodium citrate also serves as an electrolyte for the newborn calf. Such electrolytes will help manage the hydration status of the newborn calf. Sodium aids in the absorption and storage of water within the animal. Other suitable electrolytes for the neonatal calf nutritional supplement product formulation include sodium chloride and potassium chloride.

[0029] The preferred form of sodium citrate for formulation purposes is trisodium citrate dihydrate. Such sodium citrate should comprise about 1-10% by weight, preferably about 1-5% by weight, of the formulated neonatal calf nutritional supplement product.

[0030] Trans-400 is a 100% active, food grade antifoaming agent designed to destroy air bubbles in the aqueous environment that builds up during the food manufacturing process. It can be obtained from Applied Material Solutions, Inc. of Elkhorn, Wisconsin. As a vegetable oil based antifoaming agent, it can be added to newborn calf nutritional supplement products in the United States and some foreign countries to release air bubbles that build up during the manufacturing process so that they can escape to produce a smooth, uniform final product. When used, Trans-400 should comprise about 0.0-1.0% wt, preferably about 0.1-0.5% wt, of the formulated newborn calf nutritional supplement product.

[0031] Cassia oil is a flavor enhancer that also acts as a preservative and antimicrobial agent. Cinnamaldehyde is an essential component. It can be added to neonatal calf nutritional supplement products at about 0.1% wt level. Phenol propionoids such as oregano oil may be used as substitutes in the product formulation.

[0032] Polysorbate 80 liquid is an emulsifier that helps the oil components in the neonatal calf nutritional supplement product to integrate in water. Thus, it is a solubilizing agent. It is derived from polyethoxylated sorbitan and oleic acid and is widely available from several manufacturers. It should comprise about 0.0-3.0% wt, preferably about 0.07-0.70% wt, of the formulated neonatal calf nutritional supplement product.

[0033] Citric acid may be added to the neonatal calf nutritional supplement product as a preservative and should comprise about 0.5-3.0% wt, preferably about 1.2-1.6% wt, of the formulated neonatal calf nutritional supplement product.

[0034] Similarly, coloring agents may be added to the neonatal calf nutritional supplement product. The formulated product is milky white in color as is. FD&C Blue dye or beta-carotene are preferred coloring agents.

[0035] One successful formulation for the neonatal calf nutritional supplement of the present invention had the following preferred ranges of ingredients:

[0036] [Table 1]

[0037] The supplement is a homogenous solution when heated and packaged and a suspension at room temperature. The solution is preferably bottled when warm. The supplement is shelf stable for periods greater than 2 hours, does not require factory vacuum packaging, and does not support mold, yeast, or bacterial growth.

[0038] The process for preparing the neonatal calf nutritional supplement product of the present invention is as follows:

[0039] 1. Add water to a jacketed tank mixer vessel with impeller. Heat the water with the lid on to above about 50°C, preferably about 50-75°C, even more preferably about 52-57°C.

[0040] 2. Add half of the xanthan gum or guar gum thickener to the container and mix the composition for approximately 15 minutes at approximately 250-500 rpm depending on the batch volume.

[0041] 3. Add the other half of the xanthan gum or guar gum thickener to the container and repeat the mixing process. It takes time for the xanthan gum or guar gum to fully hydrate in water. If all of the xanthan gum or guar gum ingredients are added to the container mixture at the same time, the composition will thicken too quickly. At the same time, entrapment of air from the environment during the mixing process should be avoided.

[0042] 4. Add non-synthetic caffeine ingredients to the mixer container.

[0043] 5. Add the trisodium citrate dihydrate ingredient to the container.

[0044] 6. Turn off the heat to the mixer vessel.

[0045] 7. Add cassia oil to container.

[0046] 8. Add Polysorbate 80 to the container.

[0047] 9. Add corn syrup at about 70°F (about 21°C) to the container.

[0048] 10. Add citric acid to the container.

[0049] The final blend of the neonatal calf nutritional supplement product will generally exhibit a viscosity level of about 75-150 cps at the prevailing temperature of 50°C immediately after blending. It takes several hours for the guar or xanthan gum to fully hydrate. Once the caffeine is fully dissolved, caffeine crystals will begin to form within 12-24 hours during cooling to room temperature, with a subsequent increase in viscosity. Thus, about 24 hours after the blending process is complete, the neonatal calf nutritional supplement product will achieve its desired viscosity level of about 550-600 cps at 21°C.

[0050] The final product is preferably packaged in a 15-20 ml squeeze tube or syringe plunger which provides convenient introduction of the product into the mouth of a newborn calf.

[0051] A typical product dose of a neonatal bovine nutritional supplement is about 10-40 ml of liquid solution containing a concentrated caffeine dose of about 100-400 mg.

[0052] The above specification provides a complete description of the ingredients and preparation process of the neonatal calf nutritional supplement product of the present invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention resides in the claims hereinafter appended.

Claims

1. 1. A neonatal calf nutritional supplement that delivers a dose of natural source caffeine to a neonatal calf, the neonatal calf nutritional supplement comprising non-synthetic caffeine in a liquid form and a viscosity modifier formulated to provide a viscosity of about 400-800 centipoise at 21° C. such that the supplement is absorbed through the oral mucosal lining of the neonatal calf.

2. 10. The neonatal calf nutritional supplement of claim 1, wherein the viscosity range of the supplement product is about 500-650 cps at 21°C.

3. 2. The neonatal bovine nutritional supplement of claim 1, wherein the natural caffeine is provided by green tea, green tea extract, black tea, coffee, or cocoa.

4. 2. The neonatal bovine nutritional supplement of claim 1, wherein the natural caffeine comprises about 1-3% by weight of the supplement product.

5. 10. The neonatal calf nutritional supplement of claim 1, wherein the viscosity modifier comprises a thickening agent such as corn syrup, molasses, glycerin, vegetable oil, glucose syrup, or high fructose syrup.

6. 6. The neonatal calf nutritional supplement of claim 5, wherein the viscosity modifier comprises about 50-60% by weight of the supplement product.

7. 2. The neonatal calf nutritional supplement of claim 1, wherein the viscosity modifier comprises an additional thickening agent such as xanthan gum, guar gum, corn starch, potato starch, citric acid, formic acid, ascorbic acid, acetic acid or phosphoric acid.

8. 8. The neonatal calf nutritional supplement of claim 7, wherein the additional thickening agent comprises about 0.05-0.20% wt of the supplement product.

9. 10. The neonatal bovine nutritional supplement of claim 1 further comprising an antioxidant.

10. 10. The neonatal calf nutritional supplement of claim 9, wherein the antioxidant comprises green tea extract.

11. 10. The neonatal calf nutritional supplement of claim 1 further comprising a vegetable oil antifoaming agent to facilitate suspension of the non-synthetic caffeine in the supplement product.

12. 10. The neonatal calf nutritional supplement of claim 1 further comprising a preservative or antimicrobial agent, such as cassia oil or citric acid.

13. 10. The neonatal calf nutritional supplement of claim 1 further comprising an emulsifier such as polysorbate 80.

14. 10. The neonatal calf nutritional supplement of claim 1 further comprising an electrolyte such as sodium citrate, trisodium citrate dihydrate, sodium chloride, or potassium chloride.

15. 2. The newborn calf nutritional supplement of claim 1, wherein the green tea extract contains a concentrated amount of caffeine such that a 10-40 ml liquid dose of the supplement delivers 100-400 mg of caffeine to the newborn calf.

16. 1. A neonatal calf nutritional supplement that delivers a dose of natural source caffeine to a neonatal calf, the supplement comprising green tea extract, xanthan gum or guar gum, corn syrup, and water, the supplement having a viscosity of about 400-800 centipoise at 21° C. such that the supplement is absorbed through the oral mucosal lining of the neonatal calf.

17. 1. A neonatal calf nutritional supplement that delivers a dose of natural source caffeine to a neonatal calf, the supplement comprising green tea extract, xanthan gum or guar gum, corn syrup, and water, the supplement having a viscosity of about 400-800 centipoise at 21° C. such that the supplement is absorbed through the oral mucosal lining of the neonatal calf.

18. 1. A method of using a neonatal bovine nutritional supplement containing natural sources of caffeine for newborn calves, comprising: (a) providing a newborn calf suffering from bovine dystocia; (b) administering to the newborn calf a dose of a supplement comprising non-synthetic caffeine in liquid form and a viscosity modifier, the supplement being formulated to provide a viscosity of about 400-800 centipoise at 21° C.; and (c) The supplement is absorbed through the oral mucosal lining of the newborn calf. The method comprising:

19. 19. The method of claim 18, wherein the natural caffeine is provided by green tea extract.

20. 20. The method of claim 18, wherein the viscosity modifier comprises corn syrup and xanthan gum or guar gum.

21. 20. The method of claim 18, wherein the supplement dose comprises 10-40 ml of liquid comprising green tea extract containing a concentrated amount of caffeine, such that the supplement dose delivers 100-400 mg of caffeine to the newborn calf.

22. 1. A method for preparing a neonatal calf nutritional supplement that delivers a dose of natural source caffeine via the oral mucosal lining of a neonatal calf, comprising: (a) adding water to a mixer vessel and heating it to at least 50°C; (b) adding a thickening agent such as xanthan gum, guar gum, corn starch, potato starch, citric acid, formic acid, ascorbic acid, acetic acid, or phosphoric acid to the mixer vessel; (c) adding a non-synthetic caffeine source, such as green tea extract, green tea, black tea, or coffee, to the mixer vessel; (d) adding an additional thickening agent, such as corn syrup, molasses, glycerin, vegetable oil, glucose syrup, or high fructose syrup, to the mixer vessel; (e) allowing the mixture to stand for about 24 hours, at which time the resulting newborn calf nutritional supplement exhibits a viscosity of about 400-800 centipoise at 21° C.; A method comprising:

23. Prior to allowing the mixture to stand, step (e), one or more of the following steps may be performed: (f) adding an antioxidant, such as caffeine, to the mixer vessel; (g) adding a flavor enhancer, such as cassia oil, to the mixer vessel; (h) adding an emulsifier, such as polysorbate 80, to the mixer vessel; (i) adding a preservative, such as citric acid, to the mixer vessel; 23. A method for preparing the neonatal calf nutritional supplement of claim 22, further comprising: